Join Now

Parallel symposium 7 - Balancing the NOAC Efficacy and Safety Profile in Optimizing Patients Outcome

 
Saturday, October 16th 2021 (14:05 – 15:25)

Overview

The use of anticoagulant is currently shifting toward the use of non-vitamin K antagonist anticoagulant (NOAC). Before you start giving NOAC for your patient, join us in this session to learn about the efficacy and safety of NOAC


Program

Time Topics
14:05 - 14:20 High Risk Atrial Fibrilation Patients – Evidence and the Latest Guideline Recommendations in Stroke Prevention (Yoga Yuniadi, MD)
14:20 - 14:35 Treating and Preventing Recurrent VTE – Is There Any Safer Option? (Suko Adiarto, MD)
14:35 - 14:50 Anticoagulation Strategies in Patients with AF after PCI or ACS (Abdul Hakim Alkatiri, MD)
14:50 - 15:20 Discussion

will be updated soon
Chairperson : Muzakkir Amir, MD
Panelist : Alexander Edo Tondas, MD
  Erika Maharani, MD
Speaker : Yoga Yuniadi, MD
  Suko Adiarto, MD
  Abdul Hakim Alkatiri, MD